GemPharmatech Co (SHSE:688046) 3-Year Revenue Growth Rate : 28.50% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is GemPharmatech Co 3-Year Revenue Growth Rate?

GemPharmatech Co's Revenue per Share for the three months ended in Mar. 2024 was ¥0.37.

During the past 12 months, GemPharmatech Co's average Revenue per Share Growth Rate was 11.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 28.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 6 years, the highest 3-Year average Revenue per Share Growth Rate of GemPharmatech Co was 28.50% per year. The lowest was 28.50% per year. And the median was 28.50% per year.

Competitive Comparison of GemPharmatech Co's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, GemPharmatech Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GemPharmatech Co's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GemPharmatech Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where GemPharmatech Co's 3-Year Revenue Growth Rate falls into.

GemPharmatech Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

GemPharmatech Co (SHSE:688046) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

GemPharmatech Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of GemPharmatech Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

GemPharmatech Co (SHSE:688046) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GemPharmatech Co Ltd (SHSE:688046) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 12, Xuefu Road, Jiangbei New District, Jiangsu Province, Nanjing, CHN, 210032

Website

https://www.gempharmatech.us

GemPharmatech Co Ltd is a provider of?genetically engineered mouse?models?and services to global preclinical research and development communities. It specializes in developing animal models using cutting edge gene-editing technologies with a large collection of?cKO/KO (conditional knockout/knockout) mice, humanized mice, immunodeficient mice, and germ-free mice.

GemPharmatech Co (SHSE:688046) Headlines

No Headlines